Scientific Interchange & Workshop

Bridging Data and Expert Insights: Paving the Way for Improved CLL Outcomes

March 7th 2025

On February 13, 2025, a select group of experts in chronic lymphocytic leukemia (CLL) participated in a virtual workshop to discuss the evolving treatment landscape of CLL and discussed subjects ranging from treatment of newly diagnosed patients to therapies for those relapsed/refractory (R/R) disease. Moderated by Alexey V. Danilov, MD, PhD, the discussion covered insights into emerging treatment approaches, novel therapeutic strategies, and sequencing of available therapies to optimize patient outcomes.

Year in Review 2024: Advancements in the Management of ALK+ NSCLC

February 21st 2025

Best Practices in Managing Indolent Systemic Mastocytosis (ISM)

February 19th 2025

Disease Mechanisms, Diagnostic Challenges, and Multidisciplinary Treatment Strategies

Evolving Treatment Strategies: Managing Advanced Prostate Cancer

December 10th 2024

Exploring Recent Updates in the Treatment of Veno-Occlusive Disease in Adults and Pediatrics

October 24th 2024

Advancing Multiple Myeloma Care: From Frontline Strategies to Novel Therapies in Relapsed/Refractory Settings

October 22nd 2024

Advancements in CLL Treatment: Optimizing Outcomes with Novel Therapeutics and Strategies